Published in AIDS Weekly, September 18th, 2000
The clinical study will involve 100 patients residing in the continental United States. Candidate patients exhibit multi-drug resistance to other antivirals, which have previously received full marketing authorization and are already in general use.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.